Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

DSpace/Manakin Repository

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

Citable link to this page

. . . . . .

Title: Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Author: Cullen, Valerie; Lindfors, Maria; Ng, Juliana; Paetau, Anders; Swinton, Erika; Kolodziej, Piotr; Boston, Heather; Saftig, Paul; Woulfe, John; Myllykangas, Liisa; Schlossmacher, Michael G; Tyynelä, Jaana; Feany, Mel B.

Note: Order does not necessarily reflect citation order of authors.

Citation: Cullen, Valerie, Maria Lindfors, Juliana Ng, Anders Paetau, Erika Swinton, Piotr Kolodziej, Heather Boston, et al. 2009. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Molecular Brain 2: 5.
Full Text & Related Files:
Abstract: Background: Elevated SNCA gene expression and intracellular accumulation of the encoded α-synuclein (aSyn) protein are associated with the development of Parkinson disease (PD). To date, few enzymes have been examined for their ability to degrade aSyn. Here, we explore the effects of CTSD gene expression, which encodes the lysosomal protease cathepsin D (CathD), on aSyn processing. Results: Over-expression of human CTSD cDNA in dopaminergic MES23.5 cell cultures induced the marked proteolysis of exogenously expressed aSyn proteins in a dose-dependent manner. Unexpectedly, brain extractions, Western blotting and ELISA quantification revealed evidence for reduced levels of soluble endogenous aSyn in ctsd knock-out mice. However, these CathD-deficient mice also contained elevated levels of insoluble, oligomeric aSyn species, as detected by formic acid extraction. In accordance, immunohistochemical studies of ctsd-mutant brain from mice, sheep and humans revealed selective synucleinopathy-like changes that varied slightly among the three species. These changes included intracellular aSyn accumulation and formation of ubiquitin-positive inclusions. Furthermore, using an established Drosophila model of human synucleinopathy, we observed markedly enhanced retinal toxicity in ctsd-null flies. Conclusion: We conclude from these complementary investigations that: one, CathD can effectively degrade excess aSyn in dopaminergic cells; two, ctsd gene mutations result in a lysosomal storage disorder that includes microscopic and biochemical evidence of aSyn misprocessing; and three, CathD deficiency facilitates aSyn toxicity. We therefore postulate that CathD promotes 'synucleinase' activity, and that enhancing its function may lower aSyn concentrations in vivo.
Published Version: doi:10.1186/1756-6606-2-5
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644690/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4878945

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters